Ethan P. Lutske
Partner
-
Experience in Cross-Border Transactions
Ethan has worked on transactions across North America, Asia, and Europe.
-
Broad Transactions Experience
Ethan has represented numerous clients in both public and private mergers, tender offers, asset acquisitions, stock purchases, joint ventures, and other strategic corporate transactions.
Ethan Lutske is a partner in Wilson Sonsini Goodrich & Rosati's mergers and acquisitions practice. He has worked on transactions across North America, Asia, and Europe. He has represented numerous clients in both public and private mergers, tender offers, asset acquisitions, stock purchases, joint ventures, SPAC transactions, reverse mergers, and other strategic corporate transactions.
Experience
Ethan Lutske is a partner in Wilson Sonsini Goodrich & Rosati's mergers and acquisitions practice. He has worked on transactions across North America, Asia, and Europe. He has represented numerous clients in both public and private mergers, tender offers, asset acquisitions, stock purchases, joint ventures, SPAC transactions, reverse mergers, and other strategic corporate transactions.
Education
- J.D., New York University, 2010
- B.A., Political Science and Economics, University of California, Berkeley, 2007
Honors
- Recognized among Daily Journal’s 2024 “Top 40 Under 40”
Admissions
- State Bar of California
Credentials
Education
- J.D., New York University, 2010
- B.A., Political Science and Economics, University of California, Berkeley, 2007
Honors
- Recognized among Daily Journal’s 2024 “Top 40 Under 40”
Admissions
- State Bar of California
Select Transactions
Strategic Transactions
- Marvell Technology in multiple transactions, including its $115 billion acquisition of Lumentum, it’s $5.5 billion acquisition of its Celestial AI, and its $2.5 billion sale of its automative ethernet business to Infineon
- Jony Ive and LoveFrom in Open AI’s acquisition of IO Products and partnership with LoveFrom
- Altruist in its pending sale to Vanguard
- Reltio in its sale to SAP
- Windsurf in its sale to Cognition
- Contentful in its sale to Salesforce
- Headspace in its sale to Sword
- Homeward Health in its sale to Cityblock Health
- Salesforce, Google, AppDirect, Aurora Innovation, Arista, Encora, Rambus, Polygon Labs, and others in numerous acquisition transactions
- Whitehawk Therapeutics in its sale of its Fyarro business to Kaken
- Fluent Biosciences in its sale to Illumina
- IDbyDNA in its sale to Illumina
- Namocell in its sale to Bio-Techne
- CloudGenix in its sale to Palo Alto Networks
- Transplant Genomics in its sale to EuroFins
Public Company Acquisitions
- VMWare in its acquisition of Pivotal.io
- Pfenex in its sale to Ligand
- Electro Scientific Industries in its sale to MKS
- Invuity in its sale to Stryker Corporation
- Miramar Labs in its sale to Sientra
- Cyan Inc. its sale to Ciena
- Integrated Silicon Solution Inc. in its sale to a consortium of Chinese investors
SPAC and Reverse Merger Transactions
- Numerous operating companies in reverse merger and de-SPAC transactions, including:
- Aurora Innovation
- Lenz Therapeutics
- OnKure Therapeutics
- Aadi Biosciences
- Forte Biosciences
- Sonder
- ESS Tech
- Amprius
- Solid Power
- Inspirato
- Various representations of SPACs and similar public companies in their transactions across from operation companies in reverse merger and de-SPAC transactions, including SK Growth Opportunity and Arca Biopharma
Other Cross-Border Transactions
- FanDuel in its business combination with the U.S. operations of Paddy Power Betfair
- Infinera in its acquisition of Coriant International
- GaN Systems in its sale to Infineon
- Marvell Technology in its divestiture of its automotive ethernet business to Infineon
- Bear Robotics in its business combination with LG’s robotics division
- Onfido in its sale to Entrust
- Run.ai Labs in its sale to NVIDIA
- Silk Security in its sale to Armis
- TSI Japan in its acquisition of HUF Worldwide
Matters
Select Transactions
Strategic Transactions
- Marvell Technology in multiple transactions, including its $115 billion acquisition of Lumentum, it’s $5.5 billion acquisition of its Celestial AI, and its $2.5 billion sale of its automative ethernet business to Infineon
- Jony Ive and LoveFrom in Open AI’s acquisition of IO Products and partnership with LoveFrom
- Altruist in its pending sale to Vanguard
- Reltio in its sale to SAP
- Windsurf in its sale to Cognition
- Contentful in its sale to Salesforce
- Headspace in its sale to Sword
- Homeward Health in its sale to Cityblock Health
- Salesforce, Google, AppDirect, Aurora Innovation, Arista, Encora, Rambus, Polygon Labs, and others in numerous acquisition transactions
- Whitehawk Therapeutics in its sale of its Fyarro business to Kaken
- Fluent Biosciences in its sale to Illumina
- IDbyDNA in its sale to Illumina
- Namocell in its sale to Bio-Techne
- CloudGenix in its sale to Palo Alto Networks
- Transplant Genomics in its sale to EuroFins
Public Company Acquisitions
- VMWare in its acquisition of Pivotal.io
- Pfenex in its sale to Ligand
- Electro Scientific Industries in its sale to MKS
- Invuity in its sale to Stryker Corporation
- Miramar Labs in its sale to Sientra
- Cyan Inc. its sale to Ciena
- Integrated Silicon Solution Inc. in its sale to a consortium of Chinese investors
SPAC and Reverse Merger Transactions
- Numerous operating companies in reverse merger and de-SPAC transactions, including:
- Aurora Innovation
- Lenz Therapeutics
- OnKure Therapeutics
- Aadi Biosciences
- Forte Biosciences
- Sonder
- ESS Tech
- Amprius
- Solid Power
- Inspirato
- Various representations of SPACs and similar public companies in their transactions across from operation companies in reverse merger and de-SPAC transactions, including SK Growth Opportunity and Arca Biopharma
Other Cross-Border Transactions
- FanDuel in its business combination with the U.S. operations of Paddy Power Betfair
- Infinera in its acquisition of Coriant International
- GaN Systems in its sale to Infineon
- Marvell Technology in its divestiture of its automotive ethernet business to Infineon
- Bear Robotics in its business combination with LG’s robotics division
- Onfido in its sale to Entrust
- Run.ai Labs in its sale to NVIDIA
- Silk Security in its sale to Armis
- TSI Japan in its acquisition of HUF Worldwide
Recent Insights
Client Highlights
Firm Advises Marvell on $115 Billion Acquisition of Lumentum
On November 2, 2026, Marvell Technology, a leader in data infrastructure semiconductor solutions, announced that they have entered into a definitive agreement to acquire Lumentum, a global leader in optical and photonic technologies that power the networks and infrastructure behind artificial intelligence, cloud computing, and next-generation communications, in an all-stock transaction. Under the terms of the agreement, Lumentum stockholders will receive a fixed exchange ratio of 4.500 shares of Marvell common stock for each share of Lumentum common stock they own. The transaction has an implied enterprise value of $115 billion for Lumentum, representing approximately $1,132 per share of Lumentum common stock and a premium of approximately 23.9 percent based on each company’s unaffected closing share price as of October 28, 2026. Wilson Sonsini Goodrich & Rosati is advising Marvell on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Armada Acquisition Corp. II on Business Combination with Evernorth Holdings
On October 9, 2026, Armada Acquisition Corp. II (Armada II), a special purpose acquisition company, and Evernorth Holdings (Evernorth), a digital asset treasury company building institutional access to the XRP economy, announced the completion of their business combination. Evernorth’s common stock is expected to begin trading on the Nasdaq Stock Market on October 12, 2026, under the ticker symbol “XRPN.” Investors included Arrington Capital, SBI Group, Ripple, Pantera Capital, Kraken, and GSR, among others.
Learn More
Recent Events
Affiliated Programs
The L Suite Webinar: Buying the Team, Not the Company - Legal and Structuring Considerations in Acquihires
Wilson Sonsini will co-host The L Suite’s “Buying the Team, Not the Company: Legal and Structuring Considerations in Acquihires” webinar on March 31, 2026.
Learn More
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.